stockscountryunited states index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  cxrx stock price  concordia international corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a updated oil pauses ahead of us rig data but  weekly gain in sight a  weird things i found out about corporate america in my first  hours a ubs credit suisse profits up after strategy shift a student loan companies to feds tell states to stop regulating us a britishmade seedlip aims to woo the nondrinking crowd a prince william and kate middleton are hiring— though not for these weird five royal family jobs a set yourself up to get the most out of retirement a updated european stocks sell off as ubs falls tech worries weigh a rightmove profit rises on ad sales a how do i get a reverse mortgage to be replaced home investing quotes stocks united states cxrx overview compare quotes stock screener earnings calendar sectors nasdaq cxrx us nasdaq join td ameritrade find a broker concordia international corp watchlist createcxrxalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield  dividend  exdividend date jul   short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones apollo global management is still in talks to buy concordia healthcare jun   at  am et by amy or concordia healthcare forms committee to review strategic options apr   at  pm et by ciara linnane concordia says had held talks but cannot guarantee a deal will happen apr   at  pm et by ciara linnane concordia shares halted in afterhours trade apr   at  pm et by ciara linnane concordia healthcare says to review strategic options apr   at  pm et by ciara linnane concordia sees fiscal  revenue of  billion to  billion oct   at  am et by ciara linnane concordia unveils  guidance sees revenue of  bln to  bln oct   at  am et by ciara linnane concordia sees  eps  to  oct   at  am et by ciara linnane in the market fog a buythedip moment for the brave sep   at  am et by barbara kollmeyer concordia agrees to buy amdipharm mercury in  billion deal sep   at  am et by ciara linnane concordia expects deal to close in fourth quarter sep   at  am et by ciara linnane concordia sees amdipharm posting  mln to  mln revenue in  sep   at  am et by ciara linnane cobcordia expects deal to boost adj eps by  in first full year sep   at  am et by ciara linnane concordia healthcare agrees to buy amdipharm mercury for about  bln sep   at  am et by ciara linnane why do canadian stocks keep blowing up us hedge funds are making a bundle betting against canadian shares call it the great white short jun   at  am et on barrons online the best and worst calls of  dec   at  am et on the wall street journal good news at concordia comes with some big caveats dec   at  am et on the wall street journal time is running out for concordia international nov   at  pm et on the wall street journal success is relative at concordia international oct   at  pm et on the wall street journal another valeant parallel at concordia international aug   at  pm et on the wall street journal concordia’s uncanny comparisons to valeant continue unfortunately aug   at  pm et on the wall street journal concordia international when lawsuits don’t pay off aug   at  pm et on the wall street journal stocks to watch jc penney nordstrom dillard’s concordia aug   at  am et on the wall street journal ceo faces off with short seller in libel suit jul   at  pm et on the wall street journal deals of the day uninvited guests from china apollo still in concordia talks jun   at  am et on the wall street journal apollo still in talks to buy concordia jun   at  am et on the wall street journal blackstone carlyle depart concordia healthcare’s sale process jun   at  pm et on the wall street journal the morning leverage facing competition in china as tech companies join healthcare fray apr   at  am et on the wall street journal deals of the day dell may have to pay up goldman settles tibco suit apr   at  am et on the wall street journal concordia healthcare to review strategic alternatives apr   at  pm et on the wall street journal concerns over valeant spread to other drug makers nov   at  pm et on the wall street journal recent news other news press releases concordia international cxrx catches eye stock jumps  concordia international corp cxrx moved big last session as the company saw its shares rise almost  on the day jul   at  am et on zackscom concordia international even the knife catcher has doubts about wielding this one concordia international even the knife catcher has doubts about wielding this one jun   at  pm et on seeking alpha concordia international corp provides update on development of longterm growth strategy concordia international corp provides update on development of longterm growth strategy jun   at  am et on cnw group dryships rank  as worst stock in nasdaq dryships rank  as worst stock in nasdaq jun   at  pm et on seeking alpha redhill bio launches two gi products in us shares up  redhill bio launches two gi products in us shares up  jun   at  pm et on seeking alpha concordia international corp announces redhill biopharma has started promoting donnatal� in the us concordia international corp announces redhill biopharma has started promoting donnatal� in the us jun   at  am et on cnw group concordia international corp announces results of annual general and special meeting of shareholders concordia international corp announces results of annual general and special meeting of shareholders jun   at  pm et on cnw group uk competition watchdog to continue investigation into concordia pricing shares slip  uk competition watchdog to continue investigation into concordia pricing shares slip  may   at  am et on seeking alpha concordia international corp announces results of first cma stopgo decision concordia international corp announces results of first cma stopgo decision may   at  am et on cnw group concordia internationals cxrx ceo allan oberman q  results  earnings call transcript concordia internationals cxrx ceo allan oberman q  results  earnings call transcript may   at  pm et on seeking alpha concordia international corp  q  results  earnings call slides concordia international corp  q  results  earnings call slides may   at  am et on seeking alpha concordia international corp announces first quarter  results concordia international corp announces first quarter  results may   at  am et on cnw group concordia international corp announces two new appointments to the board of directors concordia international corp announces two new appointments to the board of directors may   at  am et on cnw group concordia international corp announces release date for first quarter  results concordia international corp announces release date for first quarter  results may   at  pm et on cnw group concordia looking more and more like an eventual zero mar   at  pm et on seeking alpha concordia internationals cxrx ceo allan oberman q  results  earnings call transcript mar   at  pm et on seeking alpha concordia q top line off  net loss m shares slip  premarket mar   at  am et on seeking alpha uk competition watchdog says concordia and actavis may have colluded on drug prices mar   at  am et on seeking alpha concordia international cxrx looks good stock jumps  feb   at  am et on zackscom thinking simply about pharma rollups jan   at  am et on seeking alpha daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte jun   at  am et on pr newswire  prf corporate news blog  concordia announces review of strategic alternatives views itself on the auction block to repay its  billion debt corporate news blog  concordia announces review of strategic alternatives views itself on the auction block to repay its  billion debt jun   at  am et on accesswire concordia international corp provides update on development of longterm growth strategy concordia international corp provides update on development of longterm growth strategy jun   at  am et on pr newswire  prf redhill biopharma initiates promotion of donnatalr and enteragamr in the us redhill biopharma initiates promotion of donnatalr and enteragamr in the us jun   at  am et on globe newswire redhill biopharma initiates promotion of donnatalr and enteragamr in the us redhill biopharma initiates promotion of donnatalr and enteragamr in the us jun   at  am et on globenewswire concordia international corp announces redhill biopharma has started promoting donnatalœ in the us concordia international corp announces redhill biopharma has started promoting donnatalœ in the us jun   at  am et on pr newswire  prf concordia international corp announces results of annual general and special meeting of shareholders concordia international corp announces results of annual general and special meeting of shareholders jun   at  pm et on pr newswire  prf concordia international corp announces results of first cma stopgo decision concordia international corp announces results of first cma stopgo decision may   at  am et on pr newswire  prf biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia may   at  am et on pr newswire  prf investor network concordia international corp to host earnings call investor network concordia international corp to host earnings call may   at  am et on accesswire concordia international corp announces first quarter  results concordia international corp announces first quarter  results may   at  am et on pr newswire  prf the growth of the global pharmaceuticals market the growth of the global pharmaceuticals market may   at  am et on pr newswire  prf redhill biopharma reports  first quarter financial results redhill biopharma reports  first quarter financial results may   at  am et on globe newswire concordia international corp announces release date for first quarter  results concordia international corp announces release date for first quarter  results may   at  pm et on pr newswire  prf research reports coverage on biotech stocks  agenus intrexon progenics pharma and concordia mar   at  am et on pr newswire  prf concordia international announces fourth quarter and fiscal  results mar   at  am et on pr newswire  prf concordia international corp announces release date for fourth quarter and yearend  results mar   at  am et on pr newswire  prf redhill biopharmas copromotion partner concordia announces us district court grants treble damages relating to donnatalr mar   at  am et on globenewswire concordia international corp grant of treble damages further vindicates marketing rights of its donnatalœ brand mar   at  am et on pr newswire  prf concordia international corp comments on cma statement of objections related to hydrocortisone mg mar   at  am et on pr newswire  prf concordia international corp concordia international corp is an integrated specialty healthcare company that focuses on legacy pharmaceutical products orphan drugs and medical devices for the diabetic population it engages in the development of pharmaceutical products and medical devices the company was founded by mark l thompson on january   and is headquartered in oakville canada see full profile analyst ratings sell under hold over buy number of ratings  full ratings  biggest price target changes for wednesday feb   at  am et on benzingacom benzingas top upgrades downgrades for february   feb   at  am et on benzingacom the drug price increase debate separating the winners from the losers sep   at  am et on benzingacom competitors name chg  market cap durect corp  m biodelivery sciences international inc  m daiichi sankyo co ltd  b intercept pharmaceuticals inc  b competitor data provided by partner content trending tickers powered by amzn  spy  twtr  sbux  baba  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience cxrx key statistics  concordia international corp financial ratios  marketwatch bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close concordia international corp nasdaq cxrx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus concordia international corp after hours  quotes are delayed by  min jul    pm cxrx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description concordia international corp is an integrated specialty healthcare company that focuses on legacy pharmaceutical products orphan drugs and medical devices for the diabetic population it engages in the development of pharmaceutical products and medical devices the company was founded by mark l concordia international corp is an integrated specialty healthcare company that focuses on legacy pharmaceutical products orphan drugs and medical devices for the diabetic population it engages in the development of pharmaceutical products and medical devices the company was founded by mark l thompson on january   and is headquartered in oakville canada valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to cash flow ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total capital  total debt to total assets  longterm debt to total capital  officers and executives name age officer since title mr allan oberman   chief executive officer  director mr david j price   chief financial officer mr graeme duncan   presidentinternational segment mr francis i perier   director dr itzhak krinsky   director insider actions – purchase – sale  – number of transactions  newslatestcompanyuscxrx marketwatch news on cxrx apollo global management is still in talks to buy concordia healthcare  am june    amy or concordia healthcare forms committee to review strategic options  pm april    ciara linnane concordia says had held talks but cannot guarantee a deal will happen  pm april    ciara linnane concordia shares halted in afterhours trade  pm april    ciara linnane concordia healthcare says to review strategic options  pm april    ciara linnane concordia sees fiscal  revenue of  billion to  billion  am oct    ciara linnane concordia unveils  guidance sees revenue of  bln to  bln  am oct    ciara linnane concordia sees  eps  to   am oct    ciara linnane in the market fog a buythedip moment for the brave  am sept    barbara kollmeyer concordia agrees to buy amdipharm mercury in  billion deal  am sept    ciara linnane concordia expects deal to close in fourth quarter  am sept    ciara linnane concordia sees amdipharm posting  mln to  mln revenue in   am sept    ciara linnane cobcordia expects deal to boost adj eps by  in first full year  am sept    ciara linnane concordia healthcare agrees to buy amdipharm mercury for about  bln  am sept    ciara linnane newsnonmarketwatchcompanyuscxrx other news on cxrx concordia international cxrx catches eye stock jumps   am july    zackscom concordia international even the knife catcher has doubts about wielding this one  pm june    seeking alpha dryships rank  as worst stock in nasdaq  pm june    seeking alpha redhill bio launches two gi products in us shares up   pm june    seeking alpha uk competition watchdog to continue investigation into concordia pricing shares slip   am may    seeking alpha concordia internationals cxrx ceo allan oberman q  results  earnings call transcript  pm may    seeking alpha concordia international corp  q  results  earnings call slides  am may    seeking alpha concordia looking more and more like an eventual zero  pm march    seeking alpha concordia internationals cxrx ceo allan oberman q  results  earnings call transcript  pm march    seeking alpha concordia q top line off  net loss m shares slip  premarket  am march    seeking alpha uk competition watchdog says concordia and actavis may have colluded on drug prices  am march    seeking alpha concordia international cxrx looks good stock jumps   am feb    zackscom thinking simply about pharma rollups  am jan    seeking alpha  reasons my dividend portfolio appreciated  in   am jan    seeking alpha redhill bio to copromote concordias gi drug donnatal in us shares ahead  premarket  am jan    seeking alpha concordia executive retirement another ominous sign  pm dec    seeking alpha the best and worst us calls of   pm dec    the wall street journal interactive edition biggest movers in manufacturing stocks now – loxo cxrx orex ocul  am dec    investorplacecom concordia international provides business update  am dec    seeking alpha steven cohen adds to fairmount santrol ophthotech  am dec    gurufocuscom loading more headlines at a glance concordia international corp  lakeshore road east suite  oakville ontario lh j phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue b net income b  sales growth  employees  annual report for cxrx newspressreleasecompanyuscxrx press releases on cxrx daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte  am june    pr newswire  prf corporate news blog  concordia announces review of strategic alternatives views itself on the auction block to repay its  billion debt  am june    accesswire concordia international corp provides update on development of longterm growth strategy  am june    pr newswire  prf redhill biopharma initiates promotion of donnatalr and enteragamr in the us  am june    globe newswire concordia international corp announces redhill biopharma has started promoting donnatalœ in the us  am june    pr newswire  prf redhill biopharma initiates promotion of donnatalr and enteragamr in the us  am june    globenewswire concordia international corp announces results of annual general and special meeting of shareholders  pm june    pr newswire  prf concordia international corp announces results of first cma stopgo decision  am may    pr newswire  prf biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia  am may    pr newswire  prf investor network concordia international corp to host earnings call  am may    accesswire concordia international corp announces first quarter  results  am may    pr newswire  prf the growth of the global pharmaceuticals market  am may    pr newswire  prf redhill biopharma reports  first quarter financial results  am may    globe newswire concordia international corp announces release date for first quarter  results  pm may    pr newswire  prf research reports coverage on biotech stocks  agenus intrexon progenics pharma and concordia  am march    pr newswire  prf concordia international announces fourth quarter and fiscal  results  am march    pr newswire  prf concordia international corp announces release date for fourth quarter and yearend  results  am march    pr newswire  prf redhill biopharmas copromotion partner concordia announces us district court grants treble damages relating to donnatalr  am march    globenewswire concordia international corp grant of treble damages further vindicates marketing rights of its donnatalœ brand  am march    pr newswire  prf concordia international corp comments on cma statement of objections related to hydrocortisone mg  am march    pr newswire  prf loading more headlines log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  news  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search news  jun  concordia international corp provides update on development of longterm growth strategy jun  concordia international corp announces redhill biopharma has started promoting donnatal® in the us jun  concordia international corp announces results of annual general and special meeting of shareholders may  concordia international corp announces results of first cma stopgo decision may  concordia international corp announces first quarter  results may  concordia international corp announces two new appointments to the board of directors may  concordia international corp announces release date for first quarter  results apr  concordia international appoints david price as chief financial officer mar  concordia international announces fourth quarter and fiscal  results mar  concordia international corp announces release date for fourth quarter and yearend  results mar  concordia international corp grant of treble damages further vindicates marketing rights of its donnatal® brand mar  concordia international corp comments on cma statement of objections related to hydrocortisone mg feb  concordia international corp makes final earn out payment to cinven jan  concordia international corp announces copromote agreement for donnatal® dec  concordia international corp announces leadership transition at international segment dec  concordia international corp provides business update nov  concordia international announces third quarter  results nov  concordia international announces new leadership appointments nov  concordia international corp announces second cross currency swap agreement oct  concordia international corp announces release date for third quarter  results oct  concordia international corp announces communication with cma oct  concordia international corp announces ceo transition plan oct  concordia international announces closing of senior notes offering and appoints allan oberman to board of directors oct  concordia international announces pricing of offering of senior notes oct  concordia international announces offering of senior notes oct  concordia international exercises option to defer portion of earnout and provides update on strategic review sep  concordia international comments on health service medical supplies costs bill aug  concordia international corp issues statement on sale of company stock aug  concordia international corp announces cross currency swap agreement aug  concordia international announces second quarter  results aug  concordia international corp confirms that strategic review is ongoing and provides update on its business jul  concordia international announces release date for second quarter  results jul  concordia international corp provides additional disclosure in relation to brexits impact on its business jun  concordia international corp announces fda approval for new photofrin® laser jun  concordia healthcare corp announces name change to concordia international corp and comments on brexits impact on the companys business jun  concordia healthcare announces pdt with photofrin® data and provides corporate update jun  concordia healthcare confirms that review of strategic alternatives ongoing jun  concordia healthcare completes acquisition of four generic products may  concordia healthcare announces first quarter  results and acquisition of four products with global rights apr  concordia healthcare reports results of annual general and special meeting of shareholders apr  concordia healthcare announces formation of special committee to review strategic alternatives apr  concordia healthcare announces release date for first quarter  results mar  concordia healthcare corrects inaccurate report mar  concordia healthcare announces fourth quarter and fiscal  results and board appointment feb  concordia healthcare announces addition to senior executive team presentation at rbc investor conference and release date for fourth quarter and  results jan  concordia healthcare to present at cibc investor conference jan  concordia healthcare provides corporate update dec  concordia healthcare announces intent to repay us million debt and inclusion to nasdaq biotech index nov  concordia healthcare announces launch of first pipeline product and positive amendment to earnout terms of amco agreement nov  concordia healthcare announces third quarter  results oct  concordia healthcares mark thompson to appear on business news network today oct  concordia healthcare to host third quarter  results conference call oct  concordia healthcare announces preliminary  guidance oct  concordia healthcares mark thompson to appear on bnn today oct  concordia healthcare completes amco acquisition oct  concordia provides update on term loan financing and reconfirms blended interest rate of approximately  post amco acquisition oct  concordia healthcare announces pricing of offering of senior notes oct  concordia provides update on amco financing and capital structure post amco acquisition oct  concordia announces adoption of advance notice bylaw oct  concordia provides update on amco acquisition sep  concordia healthcare completes us million public offering of common shares at us per common share sep  concordia healthcare announces terms of us million public offering of common shares sep  concordia healthcare announces public offering of common shares sep  concordia healthcare to acquire amdipharm mercury limited amco for us billion creating a global platform to facilitate future growth aug  concordia healthcare announces second quarter  results jul  concordia healthcare corp to host second quarter  results conference call jul  concordia healthcare announces filing of preliminary base shelf prospectus jun  concordia healthcare corp reports results of annual general meeting of shareholders jun  concordia healthcare corp to commence trading on nasdaq global select market under symbol cxrx jun  concordia healthcare announces filing for a us listing may  concordia healthcare announces changes to the board of directors management team and auditors may  concordia healthcare corp announces first quarter  results may  concordia healthcare corp works to expand treatment options for patients with rare cancers apr  concordia healthcare corp to host first quarter  results conference call apr  concordia healthcare corp announces completion of acquisition of covis pharma commercial assets for us billion apr  concordia healthcare corp announces upsizing and pricing of senior notes offering apr  concordia healthcare corp closes c million bought deal financing of subscription receipts apr  concordia healthcare corp announces proposed private offering of us million senior notes due  mar  concordia healthcare announces fourth quarter and fiscal  results mar  concordia healthcare corp announces  million bought deal financing of subscription receipts mar  concordia healthcare corp to host fourth quarter and yearend  results conference call mar  concordia healthcare corp to acquire covis pharma commercial assets for us billion feb  concordia healthcare corp provides corporate update dec  concordia healthcare corp announces change to board of directors nov  concordia healthcare corp provides clinical trial and corporate update nov  concordia healthcare announces third quarter results  revenue up  ebitda up  over comparative period oct  concordia healthcare corp to host third quarter  results conference call oct  pinnacle biologics inc a subsidiary of concordia healthcare corp announces european site initiation of phase  bile duct cancer trial using photodynamic therapy with photofrin® sep  concordia healthcare corp announces completion of zonegran® acquisition sep  concordia healthcare announces agreement to acquire zonegran® in the united states and puerto rico sep  concordia healthcare corp enters into collaboration agreement with orphan canada aug  concordia healthcare corp announces financial and operational results for its second quarter ended june   aug  concordia healthcare corp announces first patients enrolled in phase  clinical trial using photodynamic therapy with photofrin® for patients with mesothelioma aug  concordia healthcare corp initiates phase  bile duct cancer trial using photodynamic therapy with photofrin® jul  concordia healthcare corp to host second quarter  results conference call jun  concordia healthcare corp reports results of annual general and special meeting of shareholders jun  concordia healthcare to present at bloom burton  co healthcare investor conference may  concordia healthcare announces successful completion of donnatal® acquisition may  concordia healthcare announces financial and operational results for its first quarter ended march   may  concordia healthcare corp to host first quarter  results conference call mar  concordia healthcare announces fiscal  results may   december  mar  fda approves optiguide® dcyl fiber optic diffuser series flexible fiber mar  concordia healthcare corp to host fiscal  yearend results conference call mar  concordia healthcare announces agreement to acquire donnatal® mar  concordia healthcare corp closes  million bought deal financing jan  concordia healthcare corp begins trading on otcqx® in us jan  concordia healthcare corp announces fda agreement on special protocol assessment for phase  clinical trial on new therapy to treat perihilar cholangiocarcinoma jan  concordia healthcare corp announces exclusive distribution agreement for ulesfia® with lachlan pharma holdings dec  concordia healthcare corp announces filing of ulesfia® with health canada dec  concordia healthcare corp announces acquisition of pinnacle biologics inc type and press “enter” to search home  concordia international corp cxr tsx  cxrx nasdaq  concordia international corp navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search more than  productsreaching a diverse patient populationin over  countrieswe are concordia international our productsconcordia international corp is focused on generic and legacy pharmaceutical products and orphan drugs learn moreour companiesconcordia international corp provides patients with safe and effective medicineslearn moreinvestorsconcordia trades on the nasdaq global select market® under the symbol cxrx and on the toronto stock exchange under the symbol cxrlearn morelatest news jun  concordia international corp provides update on development of longterm growth strategy view all news type and press “enter” to search cxrxnasdaq gs stock quote  concordia international corp  bloomberg markets error could not add to watchlist x  watchlist concordia international corp cxrxus nasdaq gs usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  concordia cxrx stock jumps ceo thompson to resign  the street  concordia cxrx stock surges explores sale of equity stake  the street there are currently no news stories for this ticker please check back later there are currently no press releases for this ticker please check back later profile concordia international corp operates as a pharmaceutical company the company focuses on the management and acquisition of legacy pharmaceutical products and the acquiring and development of orphan drugs concordia international serves customers worldwide address  lakeshore road eastsuite oakville on lj hcanada phone  website concordiarxcom executives board members allan oberman ceoexecutive director wayne kreppner presidentcoo david j price chief financial officer francesco tallarico chief legal ofcrsecy adam peeler vpinvestor relations  communications show more cxrtoronto stock quote  concordia international corp  bloomberg markets error could not add to watchlist x  watchlist concordia international corp cxrcn toronto cad   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m cad  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  global malignant mesothelioma market to reach us  mn by   persistence market research  concordia international corp provides update on development of longterm growth strategy  concordia international corp provides update on development of longterm growth strategy  canadian small cap pharma industry rises as concordia international continues to fall  dgapnews redhill biopharma initiates promotion of donnatalr and enteragamr in the us  redhill biopharma ltd redhill biopharma initiates promotion of donnatal® and enteragam® in the us  concordia international corp announces redhill biopharma has started promoting donnatal® in the us  concordia international corp announces redhill biopharma has started promoting donnatal® in the us  redhill biopharma initiates promotion of donnatal® and enteragam® in the us  concordia international corp announces results of annual general and special meeting of shareholders there are currently no press releases for this ticker please check back later profile concordia international corp operates as a pharmaceutical company the company focuses on the management and acquisition of legacy pharmaceutical products and the acquiring and development of orphan drugs concordia international serves customers worldwide address  lakeshore road eastsuite oakville on lj hcanada phone  website concordiarxcom executives board members allan oberman ceoexecutive director wayne kreppner presidentcoo david j price chief financial officer francesco tallarico chief legal ofcrsecy adam peeler vpinvestor relations  communications show more our companies  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search our companies concordia international corp pinnacle biologics incpinnacle biologics inc distributes photofrin® in the us territory and operates out of facilities in chicago for more information please visit the pinnacle biologics website at wwwpinnaclebiologicscom boucher and muir pty ltdboucher and muir is an australian company founded in  that sells specialist medical products in australia new zealand and the pacific islands for more information please visit the boucher and muir website at wwwbnmgroupcom abcur ababcur is a specialty pharmaceutical company operating in the nordic region for more information please visit the abcur website at wwwabcurse concordia laboratoriesconcordia’s orphan drugs segment is intended to provide growth opportunities through the expansion into new indications and new markets for existing or acquired orphan drugs in its initial execution of its orphan drug strategy concordia through its subsidiaries acquired the orphan drug photofrin® today photofrin® is the primary focus of the orphan drugs segment photofrin® is fdaapproved as a treatment for esophageal cancer barrett’s esophagus and nonsmall cell lung cancer concordia’s orphan drugs segment uses a thirdparty supply chain to produce and distribute photofrin® except for distribution to the us territory which distribution is completed by a concordia affiliate and product supplied in connection with clinical trials concordia pharmaceuticalsconcordia’s north america segment has a diversified product portfolio that focuses primarily on the united states pharmaceutical market this portfolio of legacy pharmaceutical products consists of branded products and authorized generic contracts the diversified product portfolio of concordia’s north america segment represents a variety of dosage strengths formulations and covers a range of therapeutic categories concordia’s north america segment seeks to acquire and manage drugs that are in the maturity or legacy stage of the pharmaceutical product lifecycle and continue on a predictable revenue generation path these products have a wellestablished record of safety and efficacy and a history of stable demand concordia international ukoperates an international specialty pharmaceutical business owning a broad portfolio of branded and generic prescription products that are sold to wholesalers hospitals and pharmacies in over  countries concordia international specializes in the acquisition licensing and development of offpatent prescription medicines which may be niche hardtomake products concordia international’s medicines are manufactured and sold through an outsourced manufacturing network and marketed internationally through a combination of direct sales and local distribution relationships concordia international’s diversified product portfolio consists of  molecules representing a variety of dosage strengths formulations and geographic markets and covering a range of therapeutic categories including endocrinology neurology ophthalmology and urology for more information please visit the concordia international website wwwconcordiarxinternationalcom type and press “enter” to search cxrx stock price  concordia international corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a updated oil pauses ahead of us rig data but  weekly gain in sight a  weird things i found out about corporate america in my first  hours a ubs credit suisse profits up after strategy shift a student loan companies to feds tell states to stop regulating us a britishmade seedlip aims to woo the nondrinking crowd a prince william and kate middleton are hiring— though not for these weird five royal family jobs a set yourself up to get the most out of retirement a updated european stocks sell off as ubs falls tech worries weigh a rightmove profit rises on ad sales a how do i get a reverse mortgage to be replaced home investing quotes stocks united states cxrx overview compare quotes stock screener earnings calendar sectors nasdaq cxrx us nasdaq join td ameritrade find a broker concordia international corp watchlist createcxrxalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield  dividend  exdividend date jul   short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones apollo global management is still in talks to buy concordia healthcare jun   at  am et by amy or concordia healthcare forms committee to review strategic options apr   at  pm et by ciara linnane concordia says had held talks but cannot guarantee a deal will happen apr   at  pm et by ciara linnane concordia shares halted in afterhours trade apr   at  pm et by ciara linnane concordia healthcare says to review strategic options apr   at  pm et by ciara linnane concordia sees fiscal  revenue of  billion to  billion oct   at  am et by ciara linnane concordia unveils  guidance sees revenue of  bln to  bln oct   at  am et by ciara linnane concordia sees  eps  to  oct   at  am et by ciara linnane in the market fog a buythedip moment for the brave sep   at  am et by barbara kollmeyer concordia agrees to buy amdipharm mercury in  billion deal sep   at  am et by ciara linnane concordia expects deal to close in fourth quarter sep   at  am et by ciara linnane concordia sees amdipharm posting  mln to  mln revenue in  sep   at  am et by ciara linnane cobcordia expects deal to boost adj eps by  in first full year sep   at  am et by ciara linnane concordia healthcare agrees to buy amdipharm mercury for about  bln sep   at  am et by ciara linnane why do canadian stocks keep blowing up us hedge funds are making a bundle betting against canadian shares call it the great white short jun   at  am et on barrons online the best and worst calls of  dec   at  am et on the wall street journal good news at concordia comes with some big caveats dec   at  am et on the wall street journal time is running out for concordia international nov   at  pm et on the wall street journal success is relative at concordia international oct   at  pm et on the wall street journal another valeant parallel at concordia international aug   at  pm et on the wall street journal concordia’s uncanny comparisons to valeant continue unfortunately aug   at  pm et on the wall street journal concordia international when lawsuits don’t pay off aug   at  pm et on the wall street journal stocks to watch jc penney nordstrom dillard’s concordia aug   at  am et on the wall street journal ceo faces off with short seller in libel suit jul   at  pm et on the wall street journal deals of the day uninvited guests from china apollo still in concordia talks jun   at  am et on the wall street journal apollo still in talks to buy concordia jun   at  am et on the wall street journal blackstone carlyle depart concordia healthcare’s sale process jun   at  pm et on the wall street journal the morning leverage facing competition in china as tech companies join healthcare fray apr   at  am et on the wall street journal deals of the day dell may have to pay up goldman settles tibco suit apr   at  am et on the wall street journal concordia healthcare to review strategic alternatives apr   at  pm et on the wall street journal concerns over valeant spread to other drug makers nov   at  pm et on the wall street journal recent news other news press releases concordia international cxrx catches eye stock jumps  concordia international corp cxrx moved big last session as the company saw its shares rise almost  on the day jul   at  am et on zackscom concordia international even the knife catcher has doubts about wielding this one concordia international even the knife catcher has doubts about wielding this one jun   at  pm et on seeking alpha concordia international corp provides update on development of longterm growth strategy concordia international corp provides update on development of longterm growth strategy jun   at  am et on cnw group dryships rank  as worst stock in nasdaq dryships rank  as worst stock in nasdaq jun   at  pm et on seeking alpha redhill bio launches two gi products in us shares up  redhill bio launches two gi products in us shares up  jun   at  pm et on seeking alpha concordia international corp announces redhill biopharma has started promoting donnatal� in the us concordia international corp announces redhill biopharma has started promoting donnatal� in the us jun   at  am et on cnw group concordia international corp announces results of annual general and special meeting of shareholders concordia international corp announces results of annual general and special meeting of shareholders jun   at  pm et on cnw group uk competition watchdog to continue investigation into concordia pricing shares slip  uk competition watchdog to continue investigation into concordia pricing shares slip  may   at  am et on seeking alpha concordia international corp announces results of first cma stopgo decision concordia international corp announces results of first cma stopgo decision may   at  am et on cnw group concordia internationals cxrx ceo allan oberman q  results  earnings call transcript concordia internationals cxrx ceo allan oberman q  results  earnings call transcript may   at  pm et on seeking alpha concordia international corp  q  results  earnings call slides concordia international corp  q  results  earnings call slides may   at  am et on seeking alpha concordia international corp announces first quarter  results concordia international corp announces first quarter  results may   at  am et on cnw group concordia international corp announces two new appointments to the board of directors concordia international corp announces two new appointments to the board of directors may   at  am et on cnw group concordia international corp announces release date for first quarter  results concordia international corp announces release date for first quarter  results may   at  pm et on cnw group concordia looking more and more like an eventual zero mar   at  pm et on seeking alpha concordia internationals cxrx ceo allan oberman q  results  earnings call transcript mar   at  pm et on seeking alpha concordia q top line off  net loss m shares slip  premarket mar   at  am et on seeking alpha uk competition watchdog says concordia and actavis may have colluded on drug prices mar   at  am et on seeking alpha concordia international cxrx looks good stock jumps  feb   at  am et on zackscom thinking simply about pharma rollups jan   at  am et on seeking alpha daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte jun   at  am et on pr newswire  prf corporate news blog  concordia announces review of strategic alternatives views itself on the auction block to repay its  billion debt corporate news blog  concordia announces review of strategic alternatives views itself on the auction block to repay its  billion debt jun   at  am et on accesswire concordia international corp provides update on development of longterm growth strategy concordia international corp provides update on development of longterm growth strategy jun   at  am et on pr newswire  prf redhill biopharma initiates promotion of donnatalr and enteragamr in the us redhill biopharma initiates promotion of donnatalr and enteragamr in the us jun   at  am et on globe newswire redhill biopharma initiates promotion of donnatalr and enteragamr in the us redhill biopharma initiates promotion of donnatalr and enteragamr in the us jun   at  am et on globenewswire concordia international corp announces redhill biopharma has started promoting donnatalœ in the us concordia international corp announces redhill biopharma has started promoting donnatalœ in the us jun   at  am et on pr newswire  prf concordia international corp announces results of annual general and special meeting of shareholders concordia international corp announces results of annual general and special meeting of shareholders jun   at  pm et on pr newswire  prf concordia international corp announces results of first cma stopgo decision concordia international corp announces results of first cma stopgo decision may   at  am et on pr newswire  prf biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia biotech stocks under scanner  biocryst pharma biogen celldex therapeutics and concordia may   at  am et on pr newswire  prf investor network concordia international corp to host earnings call investor network concordia international corp to host earnings call may   at  am et on accesswire concordia international corp announces first quarter  results concordia international corp announces first quarter  results may   at  am et on pr newswire  prf the growth of the global pharmaceuticals market the growth of the global pharmaceuticals market may   at  am et on pr newswire  prf redhill biopharma reports  first quarter financial results redhill biopharma reports  first quarter financial results may   at  am et on globe newswire concordia international corp announces release date for first quarter  results concordia international corp announces release date for first quarter  results may   at  pm et on pr newswire  prf research reports coverage on biotech stocks  agenus intrexon progenics pharma and concordia mar   at  am et on pr newswire  prf concordia international announces fourth quarter and fiscal  results mar   at  am et on pr newswire  prf concordia international corp announces release date for fourth quarter and yearend  results mar   at  am et on pr newswire  prf redhill biopharmas copromotion partner concordia announces us district court grants treble damages relating to donnatalr mar   at  am et on globenewswire concordia international corp grant of treble damages further vindicates marketing rights of its donnatalœ brand mar   at  am et on pr newswire  prf concordia international corp comments on cma statement of objections related to hydrocortisone mg mar   at  am et on pr newswire  prf concordia international corp concordia international corp is an integrated specialty healthcare company that focuses on legacy pharmaceutical products orphan drugs and medical devices for the diabetic population it engages in the development of pharmaceutical products and medical devices the company was founded by mark l thompson on january   and is headquartered in oakville canada see full profile analyst ratings sell under hold over buy number of ratings  full ratings  biggest price target changes for wednesday feb   at  am et on benzingacom benzingas top upgrades downgrades for february   feb   at  am et on benzingacom the drug price increase debate separating the winners from the losers sep   at  am et on benzingacom competitors name chg  market cap durect corp  m biodelivery sciences international inc  m daiichi sankyo co ltd  b intercept pharmaceuticals inc  b competitor data provided by partner content trending tickers powered by amzn  spy  twtr  sbux  baba  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aoil pauses ahead of us rig data but  weekly gain in sight a weird things i found out about corporate america in my first  hours aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stock information  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search stock information tsx cxr  nasdaq cxrx  type and press “enter” to search concordia international rx uk ltd concordia international rx uk ltd group search for about us concordia international is part of the concordia international corp a diverse international company focused on legacy pharmaceutical medicines and orphan drugs please see our corporate website here we have a strong international footprint and supply a diversified portfolio of more than  wellestablished offpatent molecules to patients partners and healthcare authorities in more than  countries see our medicines here we have an extensive environmental social  governance programme see here read more latest news  concordia international corp provides update on development of longterm growth strategyconcordia international corp today announced an update on the development of its longterm growth strategy  concordia international corp announces redhill biopharma has started promoting donnatal® in the usconcordia international corp today announced that redhill biopharma ltd redhill nasdaq rdhl tase rdhl a specialty biopharmaceutical company has started promoting donnatal® in certain us territoriesmore news more news products concordia international is part of the concordia international corp a diverse international company focused on legacy pharmaceutical products and orphan drugs we have a number of product ranges including concordia products amdipharm products mercury pharma products abcur products bnm products and focus pharma products for more information please visit our products page our products about us  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search about us concordia is a diverse international specialty pharmaceutical company focused on generic and legacy pharmaceutical products concordia has an international footprint with sales in more than  countries and has a diversified portfolio of more than  established offpatent products concordia also markets photofrin® for the treatment of certain rare forms of cancer the company operates out of facilities in oakville ontario and through its subsidiaries operates out of facilities in bridgetown barbados london england and mumbai india managementboard of directorscorporate governancecharters  policiesarticles  bylawsfaqs type and press “enter” to search concordia international corp provides business updatehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hrs  minssp futures dow futures nasdaq futures concordia international corp provides business updatepr newswiredecember  reblogsharetweetshareoakville on dec   prnewswire  concordia international corp concordia or the company cxrx cxrto an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs today announced that the company has paid the first installment of its earnout to cinven relating to concordias october  acquisition of amdipharm mercury limited all financial references below are in us dollars unless otherwise noted   todays payment of £ million was paid with cash on hand generated by the companys cash flows following todays payment the company has a cash balance of approximately  million the company also has up to an additional  million available under its undrawn revolving credit facility subject to compliance with certain debt incurrence covenants if drawn uponthe company believes that it has access to sufficient liquidity to meet all of its near term financial obligations as it continues to focus on developing a new long term strategic plan a few weeks into my new role as ceo and having met the majority of our employees key shareholders and debtholders i am looking forward to working with our senior management team and board of directors to chart a path forward that will help us rebuild value for all stakeholders stated mr oberman this plan will focus on managements key priorities for the company which include operational excellence portfolio expansion financial management and stakeholder outreach  we are working to execute on each of these priorities and in furtherance of our focus on operational excellence we have recently implemented the termination of the companys phase  trial for photodynamic therapy with photofrin® and the elimination of the companys contract sales force in the first phase of this plan  we look forward to providing a progress update during our regular yearend reporting anticipated in march termination of the companys phase  trial for photodynamic therapy with photofrin® the company continues to market photodynamic therapy pdt with photofrin® for its fdaapproved indications which include esophageal cancer highgrade dysplasia in barretts esophagus and nonsmall cell lung cancer however after careful consideration concordia has decided to terminate enrollment for its phase  trial which is evaluating pdt with photofrin® as a potential treatment for cholangiocarcinoma a rare form of cancer  patients currently enrolled in the phase  trial will continue through to completion the decision to end the trial does not diminish managements confidence in pdt with photofrin®s potential as a commercial product rather it is reflective of some of the challenges the company experienced enrolling the trial for a rare disease that affects a relatively small patient population the company intends to redirect its resources to other potential pdt with photofrin® opportunitieselimination of contract sales teamas part of the companys ongoing evaluation of its business concordia has decided to further reduce expenses by terminating its current contract sales team that was promoting donnatal® donnatal® is a commercial therapy prescribed to treat irritable bowel syndrome the company believes it has allocated the appropriate amount of time to assess the impact of its contract sales force on donnatal® sales and concluded that the results were not in line with expectations  management expects donnatal® to remain an important product for concordia and intends to evaluate new costeffective opportunities to market the product including copromotion arrangements nasdaq biotech indexin addition the company announced it will be removed from the nasdaq biotech index nbi effective prior to the market open today on an annual basis nasdaq reranks the nbi based on market capitalization parameters that concordia currently does not meet about concordiaconcordia is a diverse international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs the company has an international footprint with sales in more than  countries and has a diversified portfolio of more than  established offpatent molecules that make up more than  skus concordia also markets orphan drugs through its orphan drugs division consisting of photofrin® for the treatment of certain rare forms of cancerread moreconcordia operates out of facilities in oakville ontario and through its subsidiaries operates out of facilities in bridgetown barbados london england and mumbai indianotice regarding forwardlooking statements and informationthis press release includes forwardlooking statements within the meaning of the united states private securities litigation reform act of  and forwardlooking information within the meaning of canadian securities laws regarding concordia and its business which may include but are not limited to the companys cash balances the availability of the revolving credit facility the company having sufficient liquidity to meet all of its near term financial obligations the development of a new long term strategic plan rebuilding value for all stakeholders managements key priorities and the execution of those priorities the company providing progress updates including in march  continuing to market pdt with photofrin® confidence in pdt with photofrin® as a potential commercial product the potential of pdt with photofrin® the availability of other opportunities for pdt with photofrin® donnatal® remaining an important product for the company and the evaluation of new costeffective opportunities for donnatal® including copromotion opportunities often but not always forwardlooking statements and forwardlooking information can be identified by the use of words such as plans is expected expects scheduled intends contemplates anticipates believes proposes or variations including negative and grammatical variations of such words and phrases or state that certain actions events or results may could would might or will be taken occur or be achieved such statements are based on the current expectations of concordias management and are based on assumptions and subject to risks and uncertainties although concordias management believes that the assumptions underlying these statements are reasonable they may prove to be incorrect the forwardlooking events and circumstances discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting concordia including risks relating to the inability to develop a new strategic plan andor implement the companys key priorities the inability to manage the companys cash balances the inability to access the companys revolving credit facility including the inability to comply with various covenants included in the companys debt agreements the lack of access to capital to manage the companys liquidity including without limitation to meet the companys near term financial obligations the inability to create value for all stakeholders the inability to commercialize pdt with photofrin® photofrin® not growing in its respective markets or new markets donnatal® continuing to face competitive pressures the inability to enter into costeffective opportunities for donnatal® the inability to grow donnatal®s market share the loss of sales of donnatal due the inability to find an alternative to the terminated contract sales force concordias securities risks associated with developing new product indications increased indebtedness and leverage the inability to generate cash flows revenues andor stable margins the inability to grow organically the inability to repay debt andor satisfy future obligations including without limitation earn out obligations risks associated with concordias outstanding debt risks associated with the geographic markets in which concordia operates andor distributes its products risks associated with fluctuations in exchange rates including without limitation fluctuations in currencies risks associated with the use of concordias products to treat certain diseases the pharmaceutical industry and the regulation thereof regulatory investigations the failure to comply with applicable laws risks relating to distribution arrangements possible failure to realize the anticipated benefits of acquisitions andor product launches risks associated with the integration of assets and businesses into concordias business product launches the inability to launch products the fact that historical and projected financial information may not be representative of concordias future results the failure to obtain regulatory approvals economic factors market conditions acquisition opportunities risks associated with the acquisition andor launch of pharmaceutical products risks regarding clinical trials andor patient enrollment into clinical trials the equity and debt markets generally risks associated with growth and competition including without limitation with respect to concordias niche hardtomake products general economic and stock market conditions risks associated with the united kingdoms exit from the european union including without limitation risks associated with regulatory changes in the pharmaceutical industry changes in crossborder tariff and cost structures and the loss of access to the european union global trade markets risks related to patent infringement actions the loss of intellectual property rights risks and uncertainties detailed from time to time in concordias filings with the securities and exchange commission and the canadian securities administrators and many other factors beyond the control of concordia  although concordia has attempted to identify important factors that could cause actual actions events or results to differ materially from those described in forwardlooking statements and forwardlooking information there may be other factors that cause actions events or results to differ from those anticipated estimated or intended no forwardlooking statement or forwardlooking information can be guaranteed except as required by applicable securities laws forwardlooking statements and forwardlooking information speak only as of the date on which they are made and concordia undertakes no obligation to publicly update or revise any forwardlooking statement or forwardlooking information whether as a result of new information future events or otherwise in this press release cinven means depending on the context any of or collectively cinven group limited cinven partners llp cinven luxco sa cinven capital management v general partner limited and their respective associates as defined in the companies act  andor funds managed or advised by the group approximate figures  based on managements current estimatesreblogsharetweetsharerecently viewedyour list is emptywhat to read nextfj companys fj is the toyota land cruiser you really wantautoblogengineer finds pattern makes millions in stocksmoney morningsponsoredjeff bezos’ brief stint as world’s richest human ends with amazon’s secondquarter whifftechcrunchbristolmyers bmy q earnings beats estimateszacksthe next aids pandemicforeign policy magazinethis will be in everyones household by banyan hillsponsoredwednesday apple rumors iphone  enters trial productioninvestorplacesean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insidertrump’s unwitting legacy could be universal health coverageyahoo financezuckerberg wifes ambitious secret finally exposedunewzmesponsoredrepublicans kill the border taxyahoo financetwitter is only famous now because of president trump nyse traderyahoo finance videogdp — what you need to know in markets on fridayyahoo financediscover it  out of  avg by k customersdiscover cardsponsoredmattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insidera pga tour pro explained what separates jordan spieth from fellow stars like rory mcilroy and dustin johnsonbusiness insidertrump is acting suspicious because he ‘may be’ innocent fox news saysben i always hire a slew of lawyers when i havent done anything so it makes perfect sense 😂😂join the conversation   concordia international corp announces copromote agreement for donnatal®homemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hrs  minssp futures dow futures nasdaq futures concordia international corp announces copromote agreement for donnatal®cnw groupjanuary  reblogsharetweetshareperformancebased arrangement predicated on sales exceeding predetermined levels copromotional agreement is consistent with concordias strategic focus on operational excellenceoakville on  jan   cnw  concordia international corp the company cxrx cxrto  together with its subsidiaries concordia  an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs today announced it has entered into a threeyear copromotion agreement with redhill biopharma ltd  redhill  rdhl rdhlta through which the companies expect to expand sales of donnatal® concordias product used in the treatment of irritable bowel syndromeunder the terms of the agreement redhill intends to increase the promotion of donnatal® among us doctors who treat irritable bowel syndrome with marketing efforts anticipated to begin during the current quarter over the threeyear period redhill intends to promote the product in up to  sales territories redhill will incur the sales and marketing costs associated with promotional activities while concordia will provide materials and samples concordia will keep all revenue up to a predetermined level of sales and only after reaching that predetermined level will revenue be shared between the company and redhill concordia also plans to continue to sell donnatal® in us sales territories outside the scope of the redhill agreementthis agreement is a costeffective approach to promoting donnatal® in a manner consistent with our longterm strategic focus on operational excellence said allan oberman  chief executive officer of concordia  redhills commercial team is highly motivated and has previous experience in gastroenterology sales we look forward to partnering with them to market donnatal® to more key prescribers who we believe can help raise the products profile and potentially allow us to reach more patients in the usdror benasher  chief executive officer of redhill  said we are pleased to partner with concordia for the us promotion of donnatal® with a core us commercial team in place we plan to initiate promotional activities in the us in the coming months with a specialty gastrointestinal sales forceabout donnatal® donnatal® is used as adjunctive therapy for irritable bowel syndrome a condition characterized by abdominal pain bloating and diarrhea or constipation and acute enterocolitis it may also be useful as adjunctive therapy for duodenal ulcer for more information including prescribing information for donnatal® please visit wwwdonnatalcomabout redhill biopharma ltdredhill biopharma ltd nasdaqtase rdhl is a specialty biopharmaceutical company headquartered in israel  primarily focused on the development and us commercialization of late clinicalstage proprietary orallyadministered small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer redhill has a copromotion agreement with concordia for donnatal® an oral commercial adjunctive therapy in the treatment of ibs and acute enterocolitis redhills pipeline of proprietary products under development includes i rhb  an oral combination therapy for the treatment of helicobacter pylori infection with successful results from a first phase iii study ii rhb  an oral combination therapy for the treatment of crohns disease with an ongoing first phase iii study and a completed proofofconcept phase iia study for multiple sclerosis iii bekinda® rhb  a oncedaily oral pill formulation of ondansetron with an ongoing phase iii study for acute gastroenteritis and gastritis and an ongoing phase ii study for ibsd iv rhb  an encapsulated bowel preparation licensed to salix pharmaceuticals ltd v yeliva® abc  a phase iistage orallyadministered firstinclass sk selective inhibitor targeting multiple oncology inflammatory and gastrointestinal indications vi mesupron  a phase iistage firstinclass orallyadministered upa inhibitor targeting gastrointestinal and other solid tumors and vii rizaport® rhb  an oral thin film formulation of rizatriptan for acute migraines with a us nda currently under discussion with the fda and marketing authorization received in germany in october  about concordiaconcordia is a diverse international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs the company has an international footprint with sales in more than  countries and has a diversified portfolio of more than  established offpatent molecules that make up more than  skus concordia also markets orphan drugs through its orphan drugs division consisting of photofrin® for the treatment of certain rare forms of cancerread moreconcordia operates out of facilities in oakville ontario and through its subsidiaries operates out of facilities in bridgetown barbados  london england and mumbai india notice regarding forwardlooking statements and informationthis press release includes forwardlooking statements within the meaning of the united states private securities litigation reform act of  and forwardlooking information within the meaning of canadian securities laws regarding concordia and its business which may include but are not limited to the expected expansion of sales of donnatal® through the redhill copromotion agreement concordias strategic focus on operational excellence including with respect to the costeffective approach to the promotion of donnatal® the intention to increase the promotion of donnatal® among us doctors who treat irritable bowel syndrome the marketing efforts associated with the redhill copromotion agreement and the timing thereof the number of territories in which redhill will promote donnatal® redhills motivation to promote donnatal® and their prior experience in gastroenterology sales and marketing donnatal® to more key prescribers who concordia believes can help raise the products profile and potentially allow concordia to reach more patients in the us often but not always forwardlooking statements and forwardlooking information can be identified by the use of words such as plans is expected expects scheduled intends contemplates anticipates believes proposes or variations including negative and grammatical variations of such words and phrases or state that certain actions events or results may could would might or will be taken occur or be achieved such statements are based on the current expectations of concordias management and are based on assumptions and subject to risks and uncertainties although concordias management believes that the assumptions underlying these statements are reasonable they may prove to be incorrect the forwardlooking events and circumstances discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting concordia including risks associated with the inability to promote donnatal® effectively including without limitation the inability to increase the promotion of donnatal® among us doctors who treat irritable bowel syndrome the inability to grow sales of donnatal® including without limitation through the redhill copromotion agreement or due to increased competition the inability of redhill to market donnatal® effectively including without limitation with respect to any delays in agreeing to a commercialization plan with redhill  risks associated with redhill not increasing the number of territories to promote the product including without limitation the inability to promote the product in the  territories described herein redhills prior sales experience not benefiting concordia or the promotion of donnatal® the inability to market donnatal® to more prescribers risks associated with copromotion agreements including without limitation with respect to indemnity obligations termination rights acts that may be committed by copromotion partners that may result in liability to concordia or the breach of contractual obligations including unauthorized use of intellectual property or confidential information the inability to raise donnatal®s profile andor reach more patients in the us the inability of the redhill copromotion agreement to increase concordias revenues risks associated with the regulatory status of donnatal® the inability to develop a new strategic plan andor implement the companys key priorities concordias securities risks associated with developing new product indications increased indebtedness and leverage the inability to generate cash flows revenues andor stable margins the inability to grow organically the inability to repay debt andor satisfy future obligations including without limitation earn out obligations risks associated with concordias outstanding debt risks associated with the geographic markets in which concordia operates andor distributes its products risks associated with fluctuations in exchange rates including without limitation fluctuations in currencies risks associated with the use of concordias products to treat certain diseases the pharmaceutical industry and the regulation thereof regulatory investigations the failure to comply with applicable laws risks relating to distribution arrangements possible failure to realize the anticipated benefits of acquisitions andor product launches risks associated with the integration of assets and businesses into concordias business product launches the inability to launch products the fact that historical and projected financial information may not be representative of concordias future results the failure to obtain regulatory approvals economic factors market conditions acquisition opportunities risks associated with the acquisition andor launch of pharmaceutical products risks regarding clinical trials andor patient enrollment into clinical trials the equity and debt markets generally risks associated with growth and competition including without limitation with respect to concordias niche hardtomake products general economic and stock market conditions risks associated with the united kingdoms exit from the european union including without limitation risks associated with regulatory changes in the pharmaceutical industry changes in crossborder tariff and cost structures and the loss of access to the european union global trade markets risks related to patent infringement actions the loss of intellectual property rights risks and uncertainties detailed from time to time in concordias filings with the securities and exchange commission and the canadian securities administrators and many other factors beyond the control of concordia  although concordia has attempted to identify important factors that could cause actual actions events or results to differ materially from those described in forwardlooking statements and forwardlooking information there may be other factors that cause actions events or results to differ from those anticipated estimated or intended no forwardlooking statement or forwardlooking information can be guaranteed except as required by applicable securities laws forwardlooking statements and forwardlooking information speak only as of the date on which they are made and concordia undertakes no obligation to publicly update or revise any forwardlooking statement or forwardlooking information whether as a result of new information future events or otherwisesource concordia international corpreblogsharetweetsharerecently viewedyour list is emptywhat to read nextsean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insiderthis will be in everyones household by banyan hillsponsoredtrump’s unwitting legacy could be universal health coverageyahoo financerepublicans kill the border taxyahoo financetwitter is only famous now because of president trump nyse traderyahoo finance videozuckerberg wifes ambitious secret finally exposedunewzmesponsoredgdp — what you need to know in markets on fridayyahoo financemattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insidera pga tour pro explained what separates jordan spieth from fellow stars like rory mcilroy and dustin johnsonbusiness insiderengineer finds pattern makes millions in stocksmoney morningsponsoredamazon wobble creates ripples across worldwide stock marketsreutersamazon could be the first trillion dollar company nyse traderyahoo finance videorollsroyce motor ceo we’re not in the auto business we’re in the luxury businessyahoo financewomen need to carry this device with themsiren songsponsoredundefeated boxer who now fights mma on mayweathermcgregor fight i dont know if it would matter if there were  conor mcgregors in that ringbusiness insiderrepublicans warn trump no confirmation hearing for a sessions replacement and no recess appointment eitherbusiness insidertrump is acting suspicious because he ‘may be’ innocent fox news saysben i always hire a slew of lawyers when i havent done anything so it makes perfect sense 😂😂join the conversation   contact us  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search contact us concordia international corp  lakeshore road east suite  oakville ontario lj h direct  fax  infoconcordiarxcom investor relations queries investorrelationsconcordiarxcom medical information  product related inquiries  productinfoconcordiarxcom   type and press “enter” to search overview  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search overview an integrated specialty healthcare company concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs concordia trades on the nasdaq global select market® under the symbol cxrx and on the toronto stock exchange under the symbol cxr  click here to signup to receive email news updates from concordia healthcare corp for investorrelated queries please contact investorrelationsconcordiarxcom compliance hotline number  type and press “enter” to search investors  concordia international corp cxr tsx  cxrx nasdaq  navigation about us overview management board of directors corporate governance charters  policies articles  bylaws our products our companies investors overview events stock information financials analyst coverage faqs news careers contact us search investors an integrated specialty healthcare company concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs concordia trades on the nasdaq global select market® under the symbol cxrx and on the toronto stock exchange under the symbol cxr view stock information view stock information latest news jun  concordia international corp provides update on development of longterm growth strategy jun  concordia international corp announces redhill biopharma has started promoting donnatal® in the us jun  concordia international corp announces results of annual general and special meeting of shareholders downloads  first quarter report  annual report  third quarter report  second quarter report  first quarter report   view financials events q  concordia international earnings conference call may   investor relations for investorrelated queries please contact investorrelationsconcordiarxcom     type and press “enter” to search